Status:
UNKNOWN
Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial
Lead Sponsor:
University of Aarhus
Conditions:
Pancreas Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pancreatic cancer has the most dismal prognosis with a 5-year survival of 8%. The only curative treatment is surgery which is accompanied by great morbidity and mortality. Recent research indicates th...
Detailed Description
Currently, CT is the state of art for assessing and staging pancreatic cancer. However, it has its limitations when it comes to detecting small liver metastases, which are often found in pancreatic ca...
Eligibility Criteria
Inclusion
- Must be eligible for curative pancreatic resection based on CT
- Must accept randomization
Exclusion
- Not eligible for curative pancreatic resection
- Unable to undergo MRI.
- Did not accept randomization.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05253313
Start Date
May 1 2022
End Date
August 31 2024
Last Update
March 16 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.